静脉-动脉体外膜氧合患者高氧持续时间与神经功能结局
该研究回顾分析约翰斯·霍普金斯医院心血管ICU与心脏重症监护病房132例静脉-动脉体外膜氧合患者,测量首个与最高PaO2、前24小时每分钟曲线下面积及轻、中、重度高氧持续时间,主要终点为出院时改良Rankin量表评分(0-3分为神经功能良好,4-6分为不良)。127例(96.5%)在前24小时暴露于轻度高氧,105例(79.6%)神经功能不良(高氧102例 vs 无高氧3例;p=0.14)。神经功能不良者轻度(19.1 vs 15.2小时;p=0.01)、中度(14.6 vs 9.2小时;p=0.003)、重度高氧(9.1 vs 4.0小时;p=0.003)暴露更长;多因素分析中轻度(校正OR 1.10;95%CI 1.01-1.19;p=0.02)、中度(校正OR 1.12;95%CI 1.04-1.22;p=0.002)、重度(校正OR 1.19;95%CI 1.06-1.35;p=0.003)高氧持续时间与神经功能不良相关,重度高氧持续时间独立关联住院死亡(校正OR 1.18;95%CI 1.08-1.29;p<0.001)。
要点
- 132例静脉-动脉体外膜氧合患者中127例(96.5%)在前24小时暴露于轻度高氧,105例(79.6%)出院时神经功能不良。
- 神经功能不良者轻度高氧19.1 vs 15.2小时(p=0.01)、中度14.6 vs 9.2小时(p=0.003)、重度9.1 vs 4.0小时(p=0.003),暴露均更长。
- 多因素分析:轻度高氧持续时间校正OR 1.10(95%CI 1.01-1.19;p=0.02),中度校正OR 1.12(95%CI 1.04-1.22;p=0.002),重度校正OR 1.19(95%CI 1.06-1.35;p=0.003)。
- 重度高氧持续时间独立关联住院死亡,校正OR 1.18(95%CI 1.08-1.29;p<0.001)。
- 高氧与神经功能不良的关联在单因素比较中未达统计学显著(102 vs 3;p=0.14),多因素模型中持续时间与结局独立相关。
适用人群与场景
- 约翰斯·霍普金斯医院心血管ICU与心脏重症监护病房收治的静脉-动脉体外膜氧合患者132例。
诊断标准与关键阈值
- 神经功能结局用出院时改良Rankin量表评分定义:0-3分为神经功能良好,4-6分为神经功能不良。
- 高氧暴露指标包括首个与最高PaO2值、前24小时每分钟曲线下面积,以及轻、中、重度高氧持续时间。
研究设计与关键结果
- 回顾性分析静脉-动脉体外膜氧合患者132例,无干预;主要终点为出院时改良Rankin量表评分(0-3分良好,4-6分不良)。
- 127例(96.5%)在前24小时暴露于轻度高氧;105例(79.6%)神经功能不良(高氧102例 vs 无高氧3例;p=0.14)。
- 神经功能不良者轻度高氧19.1 vs 15.2小时(p=0.01)、中度14.6 vs 9.2小时(p=0.003)、重度9.1 vs 4.0小时(p=0.003),暴露时间均更长。
- 多因素分析:轻度高氧持续时间校正OR 1.10(95%CI 1.01-1.19;p=0.02),中度校正OR 1.12(95%CI 1.04-1.22;p=0.002),重度校正OR 1.19(95%CI 1.06-1.35;p=0.003),均与神经功能不良相关。
- 重度高氧持续时间独立关联住院死亡,校正OR 1.18(95%CI 1.08-1.29;p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在静脉-动脉体外膜氧合患者中,早期高氧的持续时间与严重程度独立关联出院时神经功能不良和死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of duration of hyperoxia on neurologic outcome and mortality in patients undergoing venoarterial extracorporeal membrane oxygenation.
DESIGN: A retrospective analysis of venoarterial extracorporeal membrane oxygenation patients admitted to the Johns Hopkins Hospital. The primary outcome was neurologic function at discharge defined by modified Rankin Scale, with a score of 0-3 defined as a good neurologic outcome, and a score of 4-6 defined as a poor neurologic outcome. Multivariable logistic regression analysis was performed to evaluate the association between hyperoxia and neurologic outcomes.
SETTING: The Johns Hopkins Hospital Cardiovascular ICU and Cardiac Critical Care Unit.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We measured first and maximum Pao2 values, area under the curve per minute over the first 24 hours, and duration of mild, moderate, and severe hyperoxia. Of 132 patients on venoarterial extracorporeal membrane oxygenation, 127 (96.5%) were exposed to mild hyperoxia in the first 24 hours. Poor neurologic outcomes were observed in 105 patients (79.6%) (102 with vs 3 without hyperoxia; p = 0.14). Patients with poor neurologic outcomes had longer exposure to mild (19.1 vs 15.2 hr; p = 0.01), moderate (14.6 vs 9.2 hr; p = 0.003), and severe hyperoxia (9.1 vs 4.0 hr; p = 0.003). In a multivariable analysis, patients with worse neurologic outcome experienced longer durations of mild (adjusted odds ratio, 1.10; 95% CI, 1.01-1.19; p = 0.02), moderate (adjusted odds ratio, 1.12; 95% CI, 1.04-1.22; p = 0.002), and severe (adjusted odds ratio, 1.19; 95% CI, 1.06-1.35; p = 0.003) hyperoxia. Additionally, duration of severe hyperoxia was independently associated with inhospital mortality (adjusted odds ratio, 1.18; 95% CI, 1.08-1.29; p < 0.001).
CONCLUSIONS: In patients undergoing venoarterial extracorporeal membrane oxygenation, duration and severity of early hyperoxia were independently associated with poor neurologic outcomes at discharge and mortality.
参考来源
- Al-Kawaz MN, Canner J, Caturegli G, et al. Duration of Hyperoxia and Neurologic Outcomes in Patients Undergoing Extracorporeal Membrane Oxygenation. Crit Care Med. 2021. PMID: 33935164. doi:10.1097/CCM.0000000000005069
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。